LMRI
Lumexa Imaging Holdings, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
12.42
▲ 0.74 (6.34%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
11.85
Prev close
11.68
Day high
12.48
Day low
11.44
Volume
477.19K
Market cap
$1.19B
P/E (TTM)
—
52W range
6.45 – 19.45
Day trading desk
Gap from prior close
+1.46%
Prior close 11.68
VWAP
12.03
+3.27% from price
Relative volume
0.69×
Normal
Session range
14.04%
11.40 – 13.00
Position in range
64%
Mid range
ATR (14D)
0.65
5.26% of price
Prior day high
11.98
PDH
Prior day low
11.44
PDL
Bid / ask spread
—
Quote not published
Session volume
425.37K
Avg 619.88K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.33%
+4.7%
1M
+15.53%
+11.8%
3M
+51.83%
+48.7%
6M
-14.64%
-25.7%
YTD
-32.86%
-45.2%
1Y
—
-20.0%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LMRI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
77.62M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 10, 26 | BRODNAX BRETT P Director |
STOCK | 19.36K | $0 | Direct |
| Jun 10, 26 | JOSEPH MOLLY E. Director |
STOCK | 19.36K | $0 | Direct |
| Jun 10, 26 | KARLIN BRIDGET E Director |
STOCK | 19.36K | $0 | Direct |
| Jun 10, 26 | COOPER HENRY LEE Director |
STOCK | 19.36K | $0 | Direct |
| Jun 10, 26 | EISENBERG GLENN A Director |
STOCK | 19.36K | $0 | Direct |
| Jun 10, 26 | LUNGREN MATTHEW Director |
STOCK | 19.36K | $0 | Direct |
| Jun 10, 26 | MITTL ROBERT LOUIS JR Director |
STOCK | 19.36K | $0 | Direct |
| May 19, 26 | BRODNAX BRETT P Director |
BUY | 35.00K | $253.75K | Direct |
| May 14, 26 | COOPER HENRY LEE Director |
BUY | 30.00K | $223.11K | Indirect |
| Feb 25, 26 | WALKER JAMES EDWARD JR. Officer |
STOCK | 12.41K | $0 | Direct |
| Dec 12, 25 | SZEKER JULIE Officer |
— | 66.18K | — | Direct |
| Dec 12, 25 | BRODNAX BRETT P Director |
STOCK | 27.03K | $0 | Direct |
| Dec 12, 25 | JOSEPH MOLLY E. Director |
STOCK | 27.03K | $0 | Direct |
| Dec 12, 25 | ZULLA CAITLIN Chief Executive Officer |
STOCK | 129.73K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BRODNAX BRETT P |
Director | 81.39K | Stock Award(Grant) |
COOPER HENRY LEE |
Director | 49.36K | Stock Award(Grant) |
EISENBERG GLENN A |
Director | 19.36K | Stock Award(Grant) |
JOSEPH MOLLY E. |
Director | 46.38K | Stock Award(Grant) |
KARLIN BRIDGET E |
Director | 19.36K | Stock Award(Grant) |
LUNGREN MATTHEW |
Director | 19.36K | Stock Award(Grant) |
MARTIN JAMES ANTHONY |
Chief Financial Officer | 54.05K | Stock Award(Grant) |
MITTL ROBERT LOUIS JR |
Director | 19.36K | Stock Award(Grant) |
SZEKER JULIE |
Officer | 147.26K | Conversion of Exercise of derivative security |
ZULLA CAITLIN |
Chief Executive Officer | 129.73K | Stock Award(Grant) |
Fundamentals
Market cap$1.19B
Enterprise value$2.10B
Revenue (TTM)$1.04B
Gross profit$154.48M
EBITDA$78.17M
Net income$-27.73M
EPS (TTM)$-0.29
Free cash flow—
Total cash$69.70M
Total debt$975.35M
Book value / share$6.40
Shares outstanding96.07M
Float22.11M
Short % of float10.70%
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E13.65
PEG ratio—
Price / sales—
Price / book1.94
EV / revenue2.01
EV / EBITDA26.85
Gross margin14.81%
Operating margin3.20%
Profit margin-2.66%
Return on equity—
Return on assets—
Debt / equity158.58
Current ratio1.44
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Total revenue | $1.02B | $948.87M | $935.92M | +7.8% |
| Operating revenue | $1.02B | $948.87M | $935.92M | +7.8% |
| Cost of revenue | $865.52M | $852.61M | $836.96M | +1.5% |
| Gross profit | $157.56M | $96.26M | $98.97M | +63.7% |
| Selling, general & admin | $90.45M | $70.36M | $55.16M | +28.6% |
| Total operating expense | $130.83M | $112.53M | $111.80M | +16.3% |
| Operating income | $26.73M | -$16.26M | -$12.83M | +264.4% |
| Net interest income | -$118.54M | -$136.03M | -$141.69M | +12.9% |
| Pre-tax income | -$32.22M | -$79.19M | -$119.25M | +59.3% |
| Tax provision | $14.88M | $14.91M | $2.98M | -0.1% |
| Net income | -$47.10M | -$94.10M | -$122.23M | +49.9% |
| Net income to common | -$47.10M | -$94.10M | -$122.23M | +49.9% |
| Basic EPS | -0.66 | -1.35 | -1.76 | +51.1% |
| Diluted EPS | -0.66 | -1.35 | -1.76 | +51.1% |
| EBIT | $86.32M | $56.83M | $22.45M | +51.9% |
| EBITDA | $141.71M | $113.96M | $94.51M | +24.4% |
| Basic shares | 70.98M | 94.57M | 69.41M | -24.9% |
| Diluted shares | 70.98M | 94.57M | 69.41M | -24.9% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $58.83M | $26.13M | $20.19M | +125.1% |
| Cash & short-term investments | $58.83M | $26.13M | $20.19M | +125.1% |
| Accounts receivable | $131.84M | $130.35M | $124.12M | +1.1% |
| Total current assets | $227.26M | $172.52M | $166.77M | +31.7% |
| Property, plant & equipment | $221.26M | $201.93M | $195.81M | +9.6% |
| Goodwill & intangibles | $848.89M | $855.34M | $865.93M | -0.8% |
| Total assets | $1.76B | $1.67B | $1.67B | +5.6% |
| Total current liabilities | $179.19M | $173.66M | $161.12M | +3.2% |
| Current debt | $14.71M | $16.00M | $13.80M | -8.1% |
| Long-term debt | $819.03M | $1.19B | $1.18B | -30.9% |
| Total debt | $962.50M | $1.31B | $1.30B | -26.5% |
| Total liabilities | $1.18B | $1.51B | $1.47B | -21.9% |
| Retained earnings | -$631.06M | -$583.96M | -$489.86M | -8.1% |
| Shareholder equity | $586.12M | $161.65M | $198.43M | +262.6% |
| Working capital | $48.07M | -$1.14M | $5.65M | +4,316.3% |
| Net tangible assets | -$262.77M | -$693.69M | -$667.50M | +62.1% |
| Shares issued | 96.11M | 94.57M | 94.57M | +1.6% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Net income | -$47.10M | -$94.10M | -$122.23M | +49.9% |
| Depreciation & amortisation | $55.39M | $57.13M | $72.07M | -3.0% |
| Stock-based compensation | $41.60M | $56.65M | $55.30M | -26.6% |
| Change in working capital | -$44.35M | -$2.60M | -$4.14M | -1,605.7% |
| Operating cash flow | $17.07M | $40.73M | $37.51M | -58.1% |
| Capital expenditure | -$23.48M | -$27.77M | -$24.01M | +15.5% |
| Investing cash flow | -$20.96M | -$22.28M | -$29.66M | +6.0% |
| Share buybacks | $0 | $0 | -$118.00K | — |
| Financing cash flow | $36.58M | -$12.50M | -$8.77M | +392.7% |
| Free cash flow | -$6.40M | $12.95M | $13.51M | -149.4% |
| End cash position | $58.83M | $26.13M | $20.19M | +125.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Total revenue | $252.54M | $267.73M | $245.00M | $248.03M | -5.7% |
| Operating revenue | $252.54M | $267.73M | $245.00M | $248.03M | -5.7% |
| Cost of revenue | $217.75M | $225.62M | $208.40M | $226.46M | -3.5% |
| Gross profit | $34.78M | $42.12M | $36.60M | $21.57M | -17.4% |
| Selling, general & admin | $20.34M | $37.19M | $17.49M | $20.12M | -45.3% |
| Total operating expense | $30.26M | $49.59M | $26.54M | $29.97M | -39.0% |
| Operating income | $4.53M | -$7.47M | $10.06M | -$8.40M | +160.6% |
| Net interest income | -$16.33M | -$28.02M | -$29.85M | -$31.39M | +41.7% |
| Pre-tax income | $3.08M | -$25.26M | -$4.31M | -$16.03M | +112.2% |
| Tax provision | $1.36M | $3.43M | $3.38M | $9.03M | -60.3% |
| Net income | $1.72M | -$28.69M | -$7.69M | -$25.06M | +106.0% |
| Net income to common | $1.72M | -$28.69M | -$7.69M | -$25.06M | +106.0% |
| Basic EPS | 0.02 | -0.38 | -0.08 | — | +105.3% |
| Diluted EPS | 0.02 | -0.38 | -0.08 | — | +105.3% |
| EBIT | $19.41M | $2.76M | $25.54M | $15.36M | +603.6% |
| EBITDA | $33.29M | $19.00M | $38.33M | $28.94M | +75.2% |
| Basic shares | 95.98M | 75.35M | 94.57M | — | +27.4% |
| Diluted shares | 95.98M | 75.35M | 94.57M | — | +27.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $51.23M | $58.83M | $191.00K | $26.13M | -12.9% |
| Cash & short-term investments | $51.23M | $58.83M | $191.00K | $26.13M | -12.9% |
| Accounts receivable | $134.08M | $131.84M | $135.51M | $130.35M | +1.7% |
| Total current assets | $221.89M | $227.26M | $165.92M | $172.52M | -2.4% |
| Property, plant & equipment | $226.30M | $221.26M | $206.98M | $201.93M | +2.3% |
| Goodwill & intangibles | $847.80M | $848.89M | $850.42M | $855.34M | -0.1% |
| Total assets | $1.76B | $1.76B | $1.69B | $1.67B | -0.1% |
| Total current liabilities | $157.93M | $179.19M | $179.99M | $173.66M | -11.9% |
| Current debt | $15.13M | $14.71M | $22.17M | $16.00M | +2.8% |
| Long-term debt | $816.97M | $819.03M | $1.18B | $1.19B | -0.3% |
| Total debt | $967.45M | $962.50M | $1.31B | $1.31B | +0.5% |
| Total liabilities | $1.16B | $1.18B | $1.52B | $1.51B | -1.2% |
| Retained earnings | -$629.34M | -$631.06M | -$602.37M | -$583.96M | +0.3% |
| Shareholder equity | $599.62M | $586.12M | $167.11M | $161.65M | +2.3% |
| Working capital | $63.95M | $48.07M | -$14.07M | -$1.14M | +33.1% |
| Net tangible assets | -$248.18M | -$262.77M | -$683.31M | -$693.69M | +5.6% |
| Shares issued | 96.08M | 96.11M | 94.57M | 94.57M | -0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Net income | $1.72M | -$28.69M | -$7.69M | -$25.06M | +106.0% |
| Depreciation & amortisation | $13.88M | $16.24M | $12.79M | $13.58M | -14.6% |
| Stock-based compensation | $12.27M | $18.57M | $6.37M | $14.04M | -33.9% |
| Change in working capital | -$28.86M | -$852.00K | -$31.29M | $18.08M | -3,287.0% |
| Operating cash flow | $2.93M | $17.10M | -$13.96M | $25.31M | -82.9% |
| Capital expenditure | -$5.31M | -$4.25M | -$1.00M | -$5.87M | -25.1% |
| Investing cash flow | -$5.27M | -$2.40M | -$720.00K | -$5.58M | -119.8% |
| Financing cash flow | -$5.26M | $43.93M | -$4.15M | -$4.93M | -112.0% |
| Free cash flow | -$2.38M | $12.85M | -$14.96M | $19.44M | -118.5% |
| End cash position | $51.23M | $58.83M | $7.30M | $26.13M | -12.9% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.14 | 0.20 | +38.9% |
| Mar 2026 | 0.12 | — | — |
| Dec 2025 | 0.05 | 0.01 | -77.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.19 | 6 | $270.18M | — |
| Next quarter | 0.21 | 6 | $279.85M | +4.5% |
| Current year | 0.77 | 6 | $1.07B | +4.2% |
| Next year | 0.91 | 6 | $1.12B | +5.4% |
Analyst targets & ownership
Mean target$17.00
High target$23.00
Low target$9.00
Implied upside36.88%
Analyst count7
ConsensusSTRONG BUY
Strong buy / Buy2 / 6
Hold0
Sell / Strong sell0 / 0
Held by insiders80.79%
Held by institutions33.45%
Institutions holding140
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
11.91
+4.28% from price
SMA 20
11.45
+8.47% from price
SMA 50
11.09
+12.00% from price
SMA 100
9.99
+24.34% from price
SMA 200
—
—
EMA 12
11.80
+5.22% from price
EMA 26
11.48
+8.19% from price
EMA 50
11.08
+12.14% from price
RSI (14)
64.3
Neutral
MACD (12,26,9)
0.32
Hist 0.04
ATR (14)
0.65
5.26% of price
Realised vol 30D
46.9%
Annualised
Bollinger upper
12.63
20, 2σ
Bollinger lower
10.27
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.62
More volatile than market
Correlation to SPY
0.26
Largely independent
Realised vol 30D
46.9%
Annualised
Market vol 1Y
13.4%
SPY, annualised
Max drawdown 1Y
-63.5%
Peak to trough
Max drawdown 5Y
-63.5%
Peak to trough
ATR 14
0.65
5.26% of price
Beta (reported)
—
5Y monthly, from filing
Short interest
Shares short
2.76M
Prior 2.82M
Change vs prior
-2.2%
Shorts covering
% of float
10.70%
Elevated
% of shares out
2.87%
Against total outstanding
Days to cover
6.2
Crowded exit
Float
22.11M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 20, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Apr 14, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Feb 9, 26 | Raymond James | UPGRADE | Outperform | Strong Buy |
| Jan 5, 26 | Raymond James | INITIATED | — | Outperform |
| Jan 5, 26 | Barclays | INITIATED | — | Overweight |
| Jan 5, 26 | Wells Fargo | INITIATED | — | Overweight |
| Jan 5, 26 | William Blair | INITIATED | — | Outperform |
| Jan 5, 26 | Deutsche Bank | INITIATED | — | Buy |
| Jan 5, 26 | Leerink Partners | INITIATED | — | Outperform |
| Jan 5, 26 | Jefferies | INITIATED | — | Buy |
SEC filings
Periodic Financial Reports
10-Q · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-08-12
Corporate Changes & Voting Matters
8-K · 2026-06-30
Corporate Changes & Voting Matters
8-K · 2026-06-12
Periodic Financial Reports
10-Q · 2026-05-12
Proxy Statements
DEF 14A · 2026-04-28
Corporate Changes & Voting Matters
8-K · 2026-04-09
Periodic Financial Reports
10-K · 2026-03-30
Headlines
Lumexa Imaging (LMRI) Q2 2026 Earnings Call Transcript
Motley Fool · 3d ago
Lumexa Imaging Holdings Inc (LMRI) (Q2 2026) Earnings Call Highlights: Record Advanced Modality ...
GuruFocus.com · 10d ago
Lumexa Imaging Q2 Earnings Call Highlights
MarketBeat · 10d ago
Lumexa: Q2 Earnings Snapshot
Associated Press · 10d ago
Lumexa Imaging Q2 Adjusted Earnings, Revenue Rise; Reaffirms 2026 Guidance
MT Newswires · 10d ago
Lumexa Imaging Announces Second Quarter 2026 Results
GlobeNewswire · 10d ago
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
GlobeNewswire · 25d ago
Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway
Zacks · 33d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.